brands of glp 1 Market Overview: GLP-1 Agonists and the Obesity Market | Blog Conagra Brands eyes GLP-1 users

PMC 3608468

Dosing protocols are highly individualized and should be managed by a clinician with experience in peptide therapy and the specific indication being treated

The study did not meet the primary endpoint of change on a measure of how much sugar the brain uses for energy, but it showed that patients on the drug had nearly 50% less shrinking in parts of the brain that control memory and learning and that treated participants had a slightly slower decline in cognitive function

10.1186/s41983-022-00452-2 Egypt J Neurol Psychiatry Neurosurg

We believe it is also important to capture performance related to health IT beyond CEHRT use only